Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · IEX Real-Time Price · USD
66.86
+0.79 (1.20%)
At close: Apr 26, 2024, 4:00 PM
65.22
-1.64 (-2.45%)
After-hours: Apr 26, 2024, 7:16 PM EDT
Nuvalent Employees
Nuvalent had 92 employees on December 31, 2023. The number of employees increased by 30 or 48.39% compared to the previous year.
Employees
92
Change (1Y)
30
Growth (1Y)
48.39%
Revenue / Employee
n/a
Profits / Employee
-$1,371,946
Market Cap
4.28B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 92 | 30 | 48.39% |
Dec 31, 2022 | 62 | 22 | 55.00% |
Dec 31, 2021 | 40 | 13 | 48.15% |
Dec 31, 2020 | 27 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Perrigo Company | 9,140 |
Merit Medical Systems | 6,950 |
Haemonetics | 3,034 |
Doximity | 977 |
Lantheus Holdings | 834 |
BridgeBio Pharma | 550 |
Madrigal Pharmaceuticals | 376 |
Krystal Biotech | 229 |
NUVL News
- 19 days ago - Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024 - PRNewsWire
- 7 weeks ago - Nuvalent to Present New Preclinical Data on HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, zidesamtinib, at AACR Annual Meeting 2024 - PRNewsWire
- 2 months ago - Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results - PRNewsWire
- 2 months ago - Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-520 - PRNewsWire
- 2 months ago - Nuvalent Initiates the Phase 2 Portion of ALKOVE-1 Clinical Trial for Patients with ALK-Positive NSCLC and other Solid Tumors - PRNewsWire
- 3 months ago - Nuvalent to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - PRNewsWire
- 3 months ago - Nuvalent Announces "OnTarget 2026" Operating Plan and Key Anticipated Milestones - PRNewsWire
- 4 months ago - Nuvalent to Present at the 42nd Annual J.P. Morgan Healthcare Conference - PRNewsWire